Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1972 1
1973 1
1975 1
1981 3
1984 4
1985 3
1986 1
1987 1
1988 1
1989 1
1990 1
1991 2
1992 4
1993 6
1994 1
1995 3
1996 7
1997 5
1998 5
1999 9
2000 11
2001 15
2002 16
2003 8
2004 13
2005 13
2006 11
2007 11
2008 10
2009 17
2010 23
2011 13
2012 13
2013 16
2014 15
2015 14
2016 13
2017 13
2018 13
2019 11
2020 16
2021 13
2022 14
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL. Garcia J, et al. Cancer Treat Rev. 2020 Jun;86:102017. doi: 10.1016/j.ctrv.2020.102017. Epub 2020 Mar 26. Cancer Treat Rev. 2020. PMID: 32335505 Free article. Review.
Initially approved for treatment of metastatic colorectal cancer in combination with chemotherapy, its indications now include metastatic breast cancer, non-small-cell lung cancer, glioblastoma, renal cell carcinoma, ovarian cancer and cervical cancer. This review provides …
Initially approved for treatment of metastatic colorectal cancer in combination with chemotherapy, its indications now include metastatic br …
Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.
Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit M. Silverman DA, et al. Cancer Res. 2021 Mar 15;81(6):1431-1440. doi: 10.1158/0008-5472.CAN-20-2793. Epub 2020 Dec 17. Cancer Res. 2021. PMID: 33334813 Free PMC article. Review.
Pleomorphic adenoma: the great mimicker of malignancy.
Hernandez-Prera JC, Skálová A, Franchi A, Rinaldo A, Vander Poorten V, Zbären P, Ferlito A, Wenig BM. Hernandez-Prera JC, et al. Histopathology. 2021 Sep;79(3):279-290. doi: 10.1111/his.14322. Epub 2021 Apr 22. Histopathology. 2021. PMID: 33368685 Review.
Lung cancer.
Herbst RS, Heymach JV, Lippman SM. Herbst RS, et al. N Engl J Med. 2008 Sep 25;359(13):1367-80. doi: 10.1056/NEJMra0802714. N Engl J Med. 2008. PMID: 18815398 Free PMC article. Review. No abstract available.
Towards a better understanding of non-exudative choroidal and macular neovascularization.
Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, Corradetti G, Cabral D, Capuano V, Miere A, Costanzo E, Bandello F, Souied E, Querques G. Sacconi R, et al. Prog Retin Eye Res. 2023 Jan;92:101113. doi: 10.1016/j.preteyeres.2022.101113. Epub 2022 Aug 13. Prog Retin Eye Res. 2023. PMID: 35970724 Review.
Pseudoxanthoma elasticum.
Germain DP. Germain DP. Orphanet J Rare Dis. 2017 May 10;12(1):85. doi: 10.1186/s13023-017-0639-8. Orphanet J Rare Dis. 2017. PMID: 28486967 Free PMC article. Review.
The first clinical sign of PXE is almost always small yellow papules on the nape and sides of the neck and in flexural areas. The papules coalesce, and the skin becomes loose and wrinkled. ...
The first clinical sign of PXE is almost always small yellow papules on the nape and sides of the neck and in flexural areas. The pap …
Targeted therapies in gynaecological cancers.
Crusz SM, Miller RE. Crusz SM, et al. Histopathology. 2020 Jan;76(1):157-170. doi: 10.1111/his.14009. Histopathology. 2020. PMID: 31846530 Review.
In gynaecological cancer, drugs targeting defective DNA repair, such as PARP inhibitors, have been approved for advanced ovarian cancer, and drugs targeting angiogenesis have been used in the treatment of advanced or recurrent ovarian and cervical cancers. Immune check-poi …
In gynaecological cancer, drugs targeting defective DNA repair, such as PARP inhibitors, have been approved for advanced ovarian cancer, and …
Bevacizumab for the treatment of cervical cancer.
Bizzarri N, Ghirardi V, Alessandri F, Venturini PL, Valenzano Menada M, Rundle S, Leone Roberti Maggiore U, Ferrero S. Bizzarri N, et al. Expert Opin Biol Ther. 2016;16(3):407-19. doi: 10.1517/14712598.2016.1145208. Expert Opin Biol Ther. 2016. PMID: 26796332 Review.
INTRODUCTION: Cervical cancer is still a major cause of morbidity and mortality in women. ...Persistent, recurrent and metastatic cervical cancers have a poor prognosis. Angiogenesis has been identified as a crucial factor for cervical cancer growth. ...
INTRODUCTION: Cervical cancer is still a major cause of morbidity and mortality in women. ...Persistent, recurrent and metastatic …
The developing spectrum of gastric-type cervical glandular lesions.
Talia KL, McCluggage WG. Talia KL, et al. Pathology. 2018 Feb;50(2):122-133. doi: 10.1016/j.pathol.2017.09.009. Epub 2017 Dec 9. Pathology. 2018. PMID: 29233547 Review.
Established benign lesions, which are rare, include simple gastric metaplasia and lobular endocervical glandular hyperplasia (LEGH) (complex gastric metaplasia). ...GAS has a much poorer prognosis than HPV-associated cervical adenocarcinoma, with propensity f …
Established benign lesions, which are rare, include simple gastric metaplasia and lobular endocervical glandular hyperplasia (LEGH) ( …
355 results